SCHEMBL9998634

SCHEMBL9998634

CCCCc1ccc(/C=C(\COC(C)=O)Cc2ccccc2)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.48
HPGD P15428 2/20 0.48
HSD17B10 Q99714 1/20 0.48
TRPV1 Q8NER1 1/20 0.40
KDM4E B2RXH2 1/20 0.40
LMNA P02545 1/20 0.40
GAA P10253 1/20 0.40
MAPT P10636 1/20 0.40
PKM P14618 1/20 0.40
CACNA1B Q00975 1/20 0.40
APBA1 Q02410 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
CYSLTR2 Q9NS75 3/20 0.39
CYSLTR1 Q9Y271 3/20 0.39
CTSK P43235 1/20 0.39
RARB P10826 1/20 0.39
S1PR1 P21453 2/20 0.39
S1PR3 Q99500 2/20 0.39
PTGES O14684 1/20 0.38
ALOX5 P09917 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9998635 1.00 ALDH1A1 (0.48) ALDH1A1HPGDHSD17B10TRPV1KDM4E
SCHEMBL9997646 0.96 ALDH1A1 (0.49) ALDH1A1HPGDHSD17B10CYSLTR2CYSLTR1
SCHEMBL9997645 0.96 ALDH1A1 (0.49) ALDH1A1HPGDHSD17B10CYSLTR2CYSLTR1
SCHEMBL9998296 0.95 ALDH1A1 (0.48) ALDH1A1HPGDHSD17B10CYSLTR2CYSLTR1
SCHEMBL9997690 0.95 ALDH1A1 (0.48) ALDH1A1HPGDHSD17B10CYSLTR2CYSLTR1
SCHEMBL9998614 0.95 ALDH1A1 (0.48) ALDH1A1HPGDHSD17B10CYSLTR2CYSLTR1
SCHEMBL9997688 0.95 ALDH1A1 (0.48) ALDH1A1HPGDHSD17B10CYSLTR2CYSLTR1
SCHEMBL9997996 0.95 ALDH1A1 (0.48) ALDH1A1HPGDHSD17B10CYSLTR2CYSLTR1
SCHEMBL9998611 0.95 ALDH1A1 (0.48) ALDH1A1HPGDHSD17B10CYSLTR2CYSLTR1
SCHEMBL9998297 0.95 ALDH1A1 (0.48) ALDH1A1HPGDHSD17B10CYSLTR2CYSLTR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8558012-B2 2-fluoro-1,3-benzodithiol 1,1,3,3-tetraoxide derivative, production method thereof, and production method of monofluoromethyl group-containing compound using the same NAGOYA INSTITUTE OF TECHNOLOGY (JP) 2013-10-15 US disclosed
US-20110319637-A1 2-FLUORO-1,3-BENZODITHIOL 1,1,3,3-TETRAOXIDE DERIVATIVE, PRODUCTION METHOD THEREOF, AND PRODUCTION METHOD OF MONOFLUOROMETHYL GROUP-CONTAINING COMPOUND USING THE SAME NAGOYA INSTITUTE OF TECHNOLOGY (JP) 2011-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110319637-A1 2-FLUORO-1,3-BENZODITHIOL 1,1,3,3-TETRAOXIDE DERIVATIVE, PRODUCTION METHOD THEREOF, AND PRODUCTION METHOD OF MONOFLUOROMETHYL GROUP-CONTAINING COMPOUND USING THE SAME CBR1, CYP1B1, CYP2F1 ALDH1A1 160/4885HPGD 1450/4885HSD17B10 317/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.